Table 2.

Comparison of the diagnostic utility of autoantibody panels in BC

Autoantibody panels	SN [%]/SP [%]/AUC	References
GAL3+PAK2+PHB2+RACK1+RUVBL1	66/84/0.81	Lacombe et al. (2013)
p-53+c-myc+HER2+NY-ESO-1+BRCA1+BRCA2+MUC1	64/85/-	Chapman et al. (2007)
ANGPTL4+DKK1+GAL1+MUC1+GFRA1+GRN+LRRC15 (+ age, BMI, race, current smoking status)	72.9/76/0.82	Evans et al. (2014)
BMI-1+HSP70+NY-ESO-1+p53	63.4/90.2/0.819	Hong et al. (2021)
RAD50+PARD3+SPP1+SAP30BP+NY-BR-62+NY-CO-58	70/91/0.808	Kostianets et al. (2017)
CyclinB1+Imp1+Koc+survivin+p16+c-myc	67.3/92.2/-	Liu et al. (2015)
CTAG1B+CTAG2+TP53+RNF216+PPHLN1+ PIP4K2C+ZBTB16+TAS2R8+WBP2NL+DOK2+ PSRC1+MN1+TRIM21	33/98/0.68	Wang, et al. (2015)
ATP6AP1+PDCD6IP+DBT+CSNK1E+FRS3+RAC3+ HOXD1+SF3A1+CTBP1+C15orf48+MYOZ2+EIF3E+ BAT4+ATF3+BMX+RAB5A+UBAP1+SOX2+GPR157+ BDNF+ZMYM6+SLC33A1+TRIM32+ALG10+TFCP2+ SERPINH1+SELL+ZNF510	80.8/61.6/0.756	Anderson et al. (2011)